Advanced company searchLink opens in new window

SGS QUAY PHARMA LIMITED

Company number 05934226

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
21 May 2024 GAZ2(A) Final Gazette dissolved via voluntary strike-off
05 Mar 2024 GAZ1(A) First Gazette notice for voluntary strike-off
27 Feb 2024 DS01 Application to strike the company off the register
15 Sep 2023 CS01 Confirmation statement made on 13 September 2023 with no updates
09 May 2023 AA Accounts for a dormant company made up to 31 December 2022
10 Nov 2022 PSC05 Change of details for Quay Pharmaceuticals Ltd as a person with significant control on 6 December 2020
10 Nov 2022 AA Accounts for a dormant company made up to 31 December 2021
16 Sep 2022 CS01 Confirmation statement made on 13 September 2022 with no updates
14 Mar 2022 AA Accounts for a dormant company made up to 31 May 2021
21 Jan 2022 MA Memorandum and Articles of Association
21 Jan 2022 RESOLUTIONS Resolutions
  • RES13 ‐ Change of company name 06/12/2021
  • RES01 ‐ Resolution of adoption of Articles of Association
15 Dec 2021 CERTNM Company name changed quay pharma LTD\certificate issued on 15/12/21
  • RES15 ‐ Change company name resolution on 2021-12-06
15 Dec 2021 CONNOT Change of name notice
08 Dec 2021 AA01 Current accounting period shortened from 31 May 2022 to 31 December 2021
07 Dec 2021 AP01 Appointment of Mr Michael Boyd as a director on 6 December 2021
07 Dec 2021 AP03 Appointment of Catherine Aldag as a secretary on 6 December 2021
07 Dec 2021 AD01 Registered office address changed from Quay House 28 Parkway Deeside Industrial Park Deeside Clwyd CH5 2NS to Rossmore Business Park Inward Way Ellesmere Port CH65 3EN on 7 December 2021
07 Dec 2021 AP01 Appointment of Mr James Mcgurk as a director on 6 December 2021
07 Dec 2021 TM01 Termination of appointment of Michael Henry Rubinstein as a director on 6 December 2021
07 Dec 2021 TM01 Termination of appointment of David Hugh Patterson as a director on 6 December 2021
07 Dec 2021 TM02 Termination of appointment of David Hugh Patterson as a secretary on 6 December 2021
24 Sep 2021 CS01 Confirmation statement made on 13 September 2021 with no updates
10 Feb 2021 AA Accounts for a dormant company made up to 31 May 2020
25 Sep 2020 CS01 Confirmation statement made on 13 September 2020 with no updates
27 Feb 2020 AA Accounts for a dormant company made up to 31 May 2019